Purchase Order 75N94020P00707

Award Date 9/17/20
Potential Completion Date 9/30/20
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Jolla, CA 92037, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Activx Biosciences, Inc. is a $148,200 firm fixed-price purchase order for native kinase full panel profiling of 57 compounds. The contract was set aside for small businesses and has a completion date of July 2, 2020. Activx Biosciences, a foreign-owned for-profit biopharmaceutical company, provides drug discovery and development...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Activx Biosciences, Inc., a foreign-owned for-profit organization. The $180,600 contract is for kinase profiling services, with a completion date of November 29, 2022. Activx Biosciences has previously provided similar drug discovery and profiling services to other NIH entities such as the National Cancer Institute...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $5,583 purchase order to Bio X Cell, Inc. to support antibody production activities. The prime contractor Bio X Cell will deliver the requested products and services from its place of performance in Bethesda, Maryland under a firm fixed price arrangement. The period of performance for this contract is from September 7, 2017 through March 6, 2018. No set...
This federal contract award, valued at $28,222.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Applied Biosystems, LLC, a subsidiary of Life Technologies Corporation. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. The contract provides for the delivery of scientific instruments, reagents, and consumables to support the biomedical research, healthcare, and forensic analysis requirements of the NICHD, which is a civilian...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
This federal contract award, valued at $10,912.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract is for the provision of reagents and kits, with no set-aside designation. ACD is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. Through this firm-fixed-price purchase order, ACD will...
This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a leading contract research organization specializing in predictive toxicology and ADME (absorption, distribution, metabolism, and excretion) research. The $18,024.00 firm fixed-price purchase order contract is for the testing of two compounds against key ADME and DMPK (drug metabolism and...
The National Institute of Child Health and Human Development (NICHD), a civilian agency, awarded a firm-fixed-price purchase order contract worth $24,970.34 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the supply of reagent kits and probes, specifically ACD's proprietary RNAscope technology, to support biomedical research efforts across various NIH institutes. ACD has been a longstanding partner for federal research...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services. The contract was awarded to Amarex Clinical Research, LLC, a for-profit limited liability company, for a Blanket Purchase Agreement (BPA) Call with a firm fixed price of $4,400.10. The contract has an ultimate completion date of August 1, 2018. Amarex Clinical Research is a subsidiary of NSF International, a...
This is a firm fixed price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services. The contract, valued at $5,470.00, was set aside for a small disadvantaged business, Active Motif, Inc. The contract covers the provision of unspecified products or services related to the agency's mission, which likely includes biomedical research. Active Motif is a leading provider of tools and...

This is a federal contract award to Activx Biosciences, Inc. by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services. The $10,850 Firm Fixed Price contract is a replacement award for a previous contract (75N94020P00619) and has a completion date of September 30, 2020. Activx Biosciences is a foreign-owned, for-profit biopharmaceutical company that specializes in drug discovery and development services, with a focus on areas such as hematology, oncology, metabolic, and infectious diseases. The company has previously provided kinase profiling and other drug discovery services to NICHD as well as the National Institutes of Health's National Cancer Institute and National Center for Advancing Translational Sciences under other federal contract awards. This contract does not have a set-aside designation.

Generated 9/12/24, 10:54 AM